Brief Type: News
Braidwood Supreme Court Case Analysis
July 3, 2025Analysis of the potential impacts, and attendant considerations, of the Braidwood Supreme Court case prior to its resolution.
Braidwood Decision Preserves Preventative Healthcare Access
June 27, 2025HealthHIV and the National Coalition for LGBTQ Health welcome today’s Supreme Court decision in Kennedy v. Braidwood Management, Inc, which upholds the federal government’s prior position; and affirms the authority of the U.S. Preventive Services Task Force (USPSTF) in guiding coverage requirements under the Patient Protection and Affordable Care Act (ACA).
Overview: 2025 Executive Actions Impacting LGBTQ+ Health
June 16, 2025Since taking office in January 2025, President Trump has taken a series of actions that remove or weaken health protections for LGBTQ+ people. These actions collectively aim to restrict recognition of gender identity, limit access to gender-affirming care, dismantle diversity and equity programs, and reshape federal funding criteria—directly affecting the health, access, and rights of LGBTQ+ communities. These decisions are already affecting how LGBTQ+ people get care, whether services remain available, and whether health providers can serve people fairly and safely.
The Neurocognitive Effects of Aging with HIV
June 30, 2021Advancements in treatment for HIV have enabled PLWH to live long lives and by 2030, an estimated 70% of PLWH will be 50 years or older. Unfortunately, there have been many cases where PLWH develop cognitive impairments because of accelerated normal aging.
May is Hepatitis Awareness Month
May 13, 2021The CDC recommends sharing information about all the Hepatitis treatment and therapeutic options that are already widely available. They’re also asking the public to promote the CDC’s adult vaccine assessment tool, which recommends vaccines based on age, health, and occupation.
Oregon State Legislature to Allow Pharmacists to Prescribe PrEP and PEP drugs
May 12, 2021Along the lines of expanding access to (and better utilization of) routine care and prevention services, the Oregon State Legislature is poised to pass a bill that allows registered pharmacists to prescribe HIV pre-and post-exposure prophylaxis (PrEP and PEP) drugs.
Washington State Legislature Moves to Address Medicaid Drug Access and Creates STI/PrEP/PEP Workgroup
May 11, 2021In Washington state, a collective sense of relief was felt when the session’s final gavel came down on April 30th.
Biden Administration Reinstates ACA Protections for Transgender and All LGBTQ People
On Monday, May 10th, the Biden administration reinstated Obama-era protections included in the Patient Protection and Affordable Care Act (ACA) for transgender and all LGBTQ people. This move undoes the Trump administration’s reversal of these protections.
CMS Administrator Nomination Stalls
April 19, 2021The confirmation of President Joe Biden’s nomination to lead the Centers for Medicare & Medicaid Services (CMS) was delayed by top Senate Republican, Sen. John Cornyn (R-TX), over the recent Texas Medicaid waiver decision.
Gilead Sciences Proposes Change to Patient Assistance Program
April 9, 2021Gilead Sciences (Gilead) proposed a change to its Advancing Access Patient Assistance Program (PAP), which would require all PAP enrollees to receive their HIV medications (treatment and Pre-Exposure Prophylaxis (PrEP) through mail or courier delivery. This change poses significant challenges for 340B Covered Entities.
Democrats Reintroduce H.R.3., their Lower Drug Pricing Act
March 29, 2021H.R.3 would allow the federal government to negotiate directly with drug companies as a way of lowering certain Medicare drug prices; and would give the Secretary of Health and Human Services (HHS) broad authority in determining the price of those particular drugs (250 of them).
A Freeze on the Trump-Era Drug “Rebate Rule” Stalls
March 18, 2021The U.S. District Court for the District of Columbia has issued a court order delaying the Department of Health and Human Services’ (HHS) rule #0936-AA08 for almost two years. The rule, which changes payments to Pharmacy Benefit Managers in ways that disallow fluctuations based on the price of a drug, was slated to take effect January 2022.
Main Menu
Additional Resources
© Copyright 2025 National Coalition for LGBTQ Health. All rights reserved. | Privacy Policy | Site Map